Search details
1.
A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Cancer
; 122(23): 3641-3649, 2016 Dec 01.
Article
in English
| MEDLINE | ID: mdl-27648727
Results
1 -
1
de 1
1
Next >
>>